Geron
GERN
#5904
Rank
S$1.28 B
Marketcap
S$2.01
Share price
-3.09%
Change (1 day)
-13.21%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -S$60.87 Million

According to Geron's latest financial reports the company's current earnings are S$0.18 Billion. In 2024 the company made an earning of -S$0.2 Billion, an increase over its 2023 earnings that were of -S$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$60.87 Million-69.52%
2024 -S$0.2 Billion-11.23%
2023 -S$0.23 Billion30.22%
2022 -S$0.18 Billion20.15%
2021 -S$0.15 Billion50.08%
2020 -S$95.8 Million4.46%
2019 -S$91.71 Million130.68%
2018 -S$39.76 Million8.84%
2017 -S$36.53 Million-3.08%
2016 -S$37.69 Million-22080.6%
2015 S$0.17 M-100.38%
2014 -S$45.54 Million-7.14%
2013 -S$49.04 Million
2011 -S$0.12 Billion19.04%
2010 -S$97.45 Million8.45%
2009 -S$89.86 Million-2.51%
2008 -S$92.18 Million14.65%
2007 -S$80.4 Million32.68%
2006 -S$60.6 Million25.59%
2005 -S$48.25 Million4.36%
2004 -S$46.24 Million19.73%
2003 -S$38.62 Million-15.46%
2002 -S$45.68 Million1.94%
2001 -S$44.81 Million33.59%
2000 -S$33.54 Million27.53%
1999 -S$26.3 Million63.13%
1998 -S$16.13 Million15.6%
1997 -S$13.95 Million-10.66%
1996 -S$15.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
S$12.64 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$2.03 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$88.59 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.15 B-368.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.15 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA